Lenacapavir HIV prevention breakthrough in South Africa Lenacapavir HIV prevention breakthrough in South Africa is being hailed as a historic milestone in the global fight against HIV/AIDS, especially for countries grappling with high infection rates like South Africa. A newly signed agreement between the Global Fund and U.S.-based pharmaceutical company Gilead is set to deliver … Continue reading Lenacapavir HIV prevention breakthrough in South Africa